Schmidt, AF;
Nielen, M;
Withrow, SJ;
Selmic, LE;
Burton, JH;
Klungel, OH;
Groenwold, RHH;
(2016)
Chemotherapy effectiveness and mortality prediction in surgically treated osteosarcoma dogs: A validation study.
Preventive Veterinary Medicine
, 125
pp. 126-134.
10.1016/j.prevetmed.2016.01.004.
Preview |
Image
Manuscript2Figure1.tiff - Accepted Version Download (5MB) | Preview |
Preview |
Image
Manuscript2Figure2.tiff - Accepted Version Download (3MB) | Preview |
Preview |
Text
Schmidt_1474578_AFSHMIDTOSRiskCalculatorRevision1.pdf - Accepted Version Download (14kB) | Preview |
Preview |
Text
Schmidt_1474578_AFSCHMIDTManuscript2Revision1.pdf - Accepted Version Download (481kB) | Preview |
Preview |
Text
Schmidt_1474578_AFSHMIDTManuscript2Appendix1Revision1.pdf - Accepted Version Download (357kB) | Preview |
Abstract
Canine osteosarcoma is the most common bone cancer, and an important cause of mortality and morbidity, in large purebred dogs. Previously we constructed two multivariable models to predict a dog’s 5-month or 1-year mortality risk after surgical treatment for osteosarcoma. According to the 5-month model, dogs with a relatively low risk of 5-month mortality benefited most from additional chemotherapy treatment. In the present study, we externally validated these results using an independent cohort study of 794 dogs. External performance of our prediction models showed some disagreement between observed and predicted risk, mean difference: −0.11 (95% confidence interval [95% CI]-0.29; 0.08) for 5-month risk and 0.25 (95%CI 0.10; 0.40) for 1-year mortality risk. After updating the intercept, agreement improved: −0.0004 (95%CI-0.16; 0.16) and −0.002 (95%CI-0.15; 0.15). The chemotherapy by predicted mortality risk interaction (P-value = 0.01) showed that the chemotherapy compared to no chemotherapy effectiveness was modified by 5-month mortality risk: dogs with a relatively lower risk of mortality benefited most from additional chemotherapy. Chemotherapy effectiveness on 1-year mortality was not significantly modified by predicted risk (P-value = 0.28). In conclusion, this external validation study confirmed that our multivariable risk prediction models can predict a patient’s mortality risk and that dogs with a relatively lower risk of 5-month mortality seem to benefit most from chemotherapy.
| Type: | Article |
|---|---|
| Title: | Chemotherapy effectiveness and mortality prediction in surgically treated osteosarcoma dogs: A validation study |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.prevetmed.2016.01.004 |
| Publisher version: | http://dx.doi.org/10.1016/j.prevetmed.2016.01.004 |
| Language: | English |
| Additional information: | © 2016 Elsevier B.V. This manuscript is made available under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International license (CC BY-NC-ND 4.0). This license allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licenses are available at http://creativecommons.org/ licenses/by/4.0. Access may be initially restricted by the publisher. |
| Keywords: | Canine; Clinical prediction rule; Chemotherapy; Adjuvant; Personalized medicine; Oncology; Bone tumor |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Population Science and Experimental Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1474578 |
Archive Staff Only
 |
View Item |
